Semaglutide and Tirzepatide Linked to Fewer Alcohol-Related Hospital Visits

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits

Newer GLP-1 receptor agonists, including semaglutide and tirzepatide, were associated with fewer alcohol-related ED visits or hospitalizations among adults with alcohol use disorder and type 2 diabetes or obesity.

Weight loss meds could be used to stop alcoholics boozing, study suggests

Alcoholics taking weight loss drugs such as Wegovy and Mounjaro end up in hospital less, according to a study of 41,000 users. Researchers say the drugs could be explored as a possible treatment for addiction

Weight-loss drugs Wegovy and Mounjaro could slash alcohol-related hospital admissions

The analysis found GLP-1 drugs slashed the risk of alcohol-related hospital admission by 26% compared with other diabetes medicines

Fat jabs STOP binge drinking and slash hospitalisations by more than a quarter

GAMECHANGER weight loss drugs could curb alcohol abuse issues and hospital visits by more than a quarter, promising research has suggested. The...

GLP-1s linked to fewer alcohol-related hospitalisations for people with alcohol or substance use dependence

Two separate studies have report that GLP-1s are linked to fewer alcohol and substance related hospitalisations for people with alcohol or substance use dependence.In the first study, published in The Lancet Psychiatry, people with type 2 diabetes were hospitalised less frequently for alcohol or substance use disorders while undergoing treatment with GLP-1 receptor agonists, according to a large Swedish registry study involving the Central Insti…

Wegovy and heart disease: cardiovascular benefits

Evidence-led guide to Wegovy, cardiovascular risk reduction, heart attack and stroke data, safety, side effects and when to seek advice